Hydroxyethyl starch for intravenous volume replacement: more harm than benefit

JAMA. 2013 Feb 20;309(7):723-4. doi: 10.1001/jama.2013.851.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Critical Illness / mortality*
  • Fluid Therapy*
  • Humans
  • Hydroxyethyl Starch Derivatives / adverse effects*

Substances

  • Hydroxyethyl Starch Derivatives